The CO2RE® System for Vulvar Lichen Sclerosus

Status Completed

Clinical Trial Summary

Subjects with vulvar lichen sclerosus (VLS) will undergo fractional carbon dioxide (CO2) laser treatment to the vulvar area. Subjects will be evaluated for changes in clinical signs and architectural changes associated with VLS at designated follow-ups to 1-year post treatment series.

Clinical Trial Description

This study is a prospective, non-randomized, single-group assignment, interventional clinical trial. Female subjects with vulvar lichen sclerosus (VLS) supported by histologic findings on biopsy and/or clinical signs on physical examination and recalcitrant to mid- to high-potency steroid therapy, will undergo up to 5 monthly treatments to the vulva with a fractional CO2 laser. Investigators will assess clinical signs and architectural changes associated with VLS. Baseline measurements will be compared to follow-up at 6 weeks, 3 months, 6 months and 12 months after the final treatment. Subjects will self report sexual function using a validated FSFI Questionnaire at baseline and at the 3- and 6-month follow-ups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04148651
Study type	Interventional
Source	Candela Corporation
Contact
Status	Completed
Phase	N/A
Start date	July 11, 2018
Completion date	December 17, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03961126` - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.	Phase 2
Completed	`NCT03686800` - The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients	N/A
Completed	`NCT05147129` - Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Completed	`NCT02573883` - Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus	Phase 3
Recruiting	`NCT06132919` - Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)	Phase 2
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Terminated	`NCT01126255` - Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus	Phase 2
Recruiting	`NCT04951206` - Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus	Phase 4
Recruiting	`NCT05250466` - A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia	N/A
Active, not recruiting	`NCT03926299` - Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus	N/A
Completed	`NCT02416531` - Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser	N/A
Recruiting	`NCT04967170` - A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus	Phase 1/Phase 2
Active, not recruiting	`NCT04134494` - Laser Treatment for Vulvar Lichen Sclerosus	N/A
Completed	`NCT05251220` - Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Completed	`NCT01400022` - Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus	N/A
Recruiting	`NCT06360705` - StrataMGT for the Treatment of Vulvar Lichen Sclerosus	N/A
Completed	`NCT00757874` - Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus	Phase 2
Recruiting	`NCT05243563` - Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?	Phase 2/Phase 3